AbbVie Inc. (ABBV) Financial Statements (2024 and earlier)

Company Profile

Business Address 1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,7666,7229,22911,8799,9617,572
Cash and cash equivalents8,7596,7119,20111,8328,5216,098
Short-term investments71128471,4401,474
Receivables11,49111,47311,25410,74311,23710,733
Inventory, net of allowances, customer advances and progress billings4,0553,8333,5793,1723,3963,483
Inventory4,0553,8333,5793,1723,3963,483
Other undisclosed current assets4,5404,4604,4014,5704,5064,721
Total current assets:28,85226,48828,46330,36429,10026,509
Noncurrent Assets
Property, plant and equipment4,9434,9314,9354,8934,9585,075
Long-term investments and receivables288257241235244260
Long-term investments288257241235244260
Intangible assets, net (including goodwill)95,08697,06899,595100,451103,851106,284
Goodwill32,22432,22032,15631,72632,02832,298
Intangible assets, net (excluding goodwill)62,86264,84867,43968,72571,82373,986
Other noncurrent assets6,1985,8005,5715,3825,0335,083
Total noncurrent assets:106,515108,056110,342110,961114,086116,702
TOTAL ASSETS:135,367134,544138,805141,325143,186143,211
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:27,03624,78925,40223,50522,54322,569
Accounts payable   2,934   
Accrued liabilities   10,282   
Other undisclosed accounts payable and accrued liabilities27,03624,78912,18623,50522,54322,569
Debt5,2032,8014,1369,20711,9309,952
Total current liabilities:32,23927,59029,53832,71234,47332,521
Noncurrent Liabilities
Long-term debt and lease obligation, including:55,81259,29259,13560,39961,00263,522
Finance lease, liability   17   
Other undisclosed long-term debt and lease obligation55,81259,29259,11860,39961,00263,522
Liabilities, other than long-term debt34,41834,35932,84532,18733,02330,854
Deferred income tax liabilities2,1242,1102,1901,9722,2552,831
Other liabilities32,29432,24930,65530,21530,76828,023
Total noncurrent liabilities:90,23093,65191,98092,58694,02594,376
Total liabilities:122,469121,241121,518125,298128,498126,897
Equity
Equity, attributable to parent, including:12,86613,27417,25415,99414,65316,283
Treasury stock, value(6,528)(6,524)(4,594)(4,590)(4,591)(4,585)
Additional paid in capital19,83919,61919,24519,05618,90618,731
Accumulated other comprehensive loss(2,252)(2,232)(2,199)(3,443)(3,196)(2,984)
Retained earnings1,7892,3934,7844,9533,5165,103
Other undisclosed equity, attributable to parent181818181818
Equity, attributable to noncontrolling interest322933333531
Total equity:12,89813,30317,28716,02714,68816,314
TOTAL LIABILITIES AND EQUITY:135,367134,544138,805141,325143,186143,211

Income Statement (P&L) ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues13,86512,22515,12114,81214,58313,538
Cost of revenue(4,240)(3,986)(4,169)(5,251)(4,170)(4,052)
Cost of goods and services sold(4,240)(3,986)(4,170)(5,022)(4,170)(4,052)
Gross profit:9,6258,23910,9529,56110,4139,486
Operating expenses(5,281)(5,481)(5,450)(4,958)(7,290)(4,769)
Other operating income (expense), net 169101(229)172 
Other undisclosed operating income (loss)   (1)229  
Operating income:4,5132,7685,5024,6033,2954,717
Nonoperating income (expense)(1,351)(1,740)(1,971)357(1,556)760
Investment income, nonoperating98999063249
Other nonoperating income (expense)(1,412)(1,804)(2,021)330(1,533)776
Interest and debt expense(552)(553)(566)(560)(556)(548)
Income from continuing operations before income taxes:2,6104752,9654,4001,1834,929
Income tax expense(583)(234)(493)(448)(255)(436)
Income from continuing operations:2,0272412,4723,9529284,493
Income before gain (loss) on sale of properties:3,9529284,493
Net income:2,0272412,4723,9529284,493
Net income (loss) attributable to noncontrolling interest(3)(2)1(3)(4)(3)
Net income attributable to parent:2,0242392,4733,9499244,490
Other undisclosed net loss available to common stockholders, basic(11)(11)(11)(18)(11)(22)
Net income available to common stockholders, diluted:2,0132282,4623,9319134,468

Comprehensive Income ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income:2,0272412,4723,9529284,493
Other comprehensive income (loss)(20)(33)1,244(247)(212)(85)
Comprehensive income:2,0072083,7163,7057164,408
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(3)(2)1(3)(4)(3)
Comprehensive income, net of tax, attributable to parent:2,0042063,7173,7027124,405

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: